Immunogenicity of a triple diphtheria-tetanus-whole cell pertussis vaccine in Iranian preschool children

Iranian Journal of Immunology

Volumn 4, Issue 2, 2007, Pages 101-109

  Zarei, Saeed ^a   Jeddi Tehrani, Mahmood ^a,b   Akhondi, Mohammad Mehdi ^a   Zeraati, Hojjat ^c   Kheirkhah, Tahere ^d   Ghazanfari, Morteza ^a   Shokri, Fazel ^a,c,e  

^a AVICENNA RESEARCH INSTITUTE   (Iran)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e Avesina Research Institute   (Iran)

Author keywords

Diphtheria tetanus pertussis vaccine; ELISA; Immunization

Indexed keywords

ANTIBODY; DIPHTHERIA PERTUSSIS TETANUS VACCINE; MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY TITER; ARTICLE; BLOOD SAMPLING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIPHTHERIA; DRUG RESPONSE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH CENTER; HUMAN; IMMUNOGENICITY; IRAN; MALE; NORMAL HUMAN; PERTUSSIS; PRESCHOOL CHILD; SEROCONVERSION; TETANUS; VACCINATION;

EID: 34250852867     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. WHO. Pertussis vaccines - WHO position paper. Wkly Epidemiol Rec. 2005;80:31-9. Available from:URL: http://www.who.int/immunization/topics/ wer8004pertussis_Jan_2005.pdf
2. WHO. Tetanus vaccine-WHO position paper. Wkly Epidemiol Rec. 2006;81:198-208.Available from:URL: http://www.who.int/immunization/ wer8120tetanus_May06_position_paper.pdf
3. WHO. Diphtheria vaccine-WHO position paper. Wkly Epidemiol Rec. 2006; 81:21-32. Available from:URL: http://www.who.int/wer/2006/wer8103.pdf
4. Plotkin SA, Cadoz M. The acellular pertussis vaccine trials: an interpretation. Pediatr Infect Dis J. 1997;16:508-17.
5. Ramsay ME, Farrington CP, Miller E. Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods. Epidemiol Infect.1993;111:41- 8.
6. Muller AS, Leeuwenburg J, Pratt DS. Pertussis: epidemiology and control. Bull World Health Organ 1986; 64:321-31.
7. Fine PE, Clarkson JA. Reflections on the efficacy of pertussis vaccines. Rev Infect Dis. 1987;9:866-83.
8. Wintermeyer SM, Nahata MC, Kyllonen KS. Whole-cell and acellular pertussis vaccines. The Ann pharmacother. 1994;28:925-39.
9. Crowcroft NS, Pebody RG. Recent developments in pertussis. Lancet 2006;367:1926-36.
10. Vaccine preventable deaths and the Global Immunization Vision and Strategy, 2006-2015.Morb Mortal Wkly Rep 2006;55:511-515. Available from: URL:http://www.who.int/vaccines-documents/DocsPDF05/GIVS_Final_EN.pdf
11. Mirchamcy H. Study on diphtheria, tetanus combined immunization in children in some elementary school of Tehran. Arch Inst Razi. 1960; 12:9-18.
12. Mirchamcy H. The use of dried whole blood absorbed on filter paper for the evaluation of diphtheria and tetanus antitoxine in mass survey. Arch Inst Razi. 1969;21:7-15.
13. Mirchamcy H. Resultats De immunisation collective des infants En Iran avecles immunogenes De production locale. Arch Inst Razi. 1982; 33:73-78.
14. Nazari F MH. Mass immunity against diphtheria and tetanus in some urban and rural areas in Iran. Arch Inst Razi. 1973;25: 49-55.
15. Nazari F MH, Aleagha S,Mahinpour. A model for developing countries of mass serological survey of children vaccinated against diphtheria and tetanus. Arch Inst Razi. 1977;29:3-10.
16. Immunization summary 2006. UNICEF.2006. Availabe from:URL: http://www.unicef.org/publications/files/Immunization_Summary_2006.pdf
17. Immunization summary2006. WHO. 2006. Available from:URL: http://www.who.int/vaccinesdocuments/GlobalSummary/GlobalSummary.pdf
18. Kosuwon P, Warachit B, Hutagalung Y, Borkird T, Kosalaraksa P, Bock HL et al. Reactogenicity and immunogenicity of reduced antigen content diphtheria-tetanus-acellular pertussis vaccine (dTpa) administered as a booster to 4-6 year-old children primed with four doses of whole-cell pertussis vaccine. Vaccine. 2003; 21:4194-200.
19. Kjeldsen K, Simonsen O, Heron I. Immunity against diphtheria and tetanus in the age group 30-70 years. Scand J Infect Dis. 1988;20: 177-85.
20. Konda T, Kamachi K, Iwaki M, Matsunaga Y. Distribution of pertussis antibodies among different age groups in Japan. Vaccine. 2002; 20:1711-7.
21. Forsyth K, Nagai M, Lepetic A, Trindade E. Pertussis immunization in the global pertussis initiative international region: recommended strategies and implementation considerations. Pediatr Infect Dis J. 2005; 24:S93-7.
22. Van Damme P, Burgess M. Immunogenicity of a combined diphtheria-tetanus- acellular pertussis vaccine in adults. Vaccine. 2004; 22:305-8.
23. Akhavizadegan M. Evaluation and comparison of immunogenicity and reactogenicity of DTP vaccines produced in Iran and other countries in Iranian infants. PhD thesis of Medical Epidemiology, School of Public Health, Tehran University of Medical Sciences, Tehran, 1996.
24. Halperin SA, Scheifele D, Mills E, Guasparini R, Humphreys G, Barreto L et al. Nature, evolution, and appraisal of adverse events and antibody response associated with the fifth consecutive dose of a five-component acellular pertussis-based-combination vaccine. Vaccine. 2003; 21:2298-306.
25. Langue J, Matisse N, Pacoret P, Undreiner F, Boisnard F, Soubeyrand B. Persistence of antibodies at 5-6 years of age for children who had received a primary series vaccination with a pentavalent whole-cell pertussis vaccine and a first booster with a pentavalent acellular pertussis vaccine: immunogenicity and tolerance of second booster with a tetravalent acellular vaccine at 5-6 years of age. Vaccine. 2004; 22:1406-14.
26. Huang LM, Chang LY, Tang H, Bock HL, Lu CY, Huang FY et al. Immunogenicity and reactogenicity of a reduced-antigencontent diphtheria-tetanus-acellular pertussis vaccine in healthy Taiwanese children and adolescents. J Adolesc Health. 2005;37: 517e1-517e5.
27. Tregnaghi M, Lopez P, Rocha C, Rivera L, David MP, Ruttimann R et al. A new DTPw-HB/Hib combination vaccine for primary and booster vaccination of infants in Latin America. Rev Panam Salud Publica. 2006; 19:179-88.
28. Meriste S, Lutsar I, Tamm E, Willems P. Safety and immunogenicity of a primary course and booster dose of a combined diphtheria, tetanus, acellular pertussis, hepatitis B and inactivated poliovirus vaccine. Scand J Infect Dis. 2006; 38:350-6.
29. Christy C, Pichichero ME, Reed GF, Decker MD, Anderson EL, Rennels MB et al. Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines. Pediatrics. 1995; 96:584-7.